Received Jun 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
Patient states she has been given PNEUMOVAX 23 four times in her lifetime, and was just recently given CAPVAXIVE. She stated she got sick with CAPVAXIVE. Customer was upset and did not want to give any further information. No additional AE/PQC.; This spontaneous report was received from patient and refers to a female patient of unknown age. The patient's medical history, past medications, current conditions and concomitant medications were not reported. On an unknown date (reported as four times in her lifetime), patient had been vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) at 0.50 mL (strength, dose number, route of administration, anatomical site of application, lot number and expiration date were not provided) and on an unknown date (reported as recently) was vaccinated with pneumococcal 21-valent conjugate vaccine solution for injection (CAPEXIVE) at 0.50 mL (strength, dose number, route of administration, anatomical site of application, lot number and expiration date were not provided) both of them administered for prophylaxis. On an unknown date, she got sick with pneumococcal 21-valent conjugate vaccine solution for injection (CAPEXIVE) (Illness). Customer was upset and did not want to give any further information. The outcome of the event was not provided. The causal relation between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) was not provided and with pneumococcal 21-valent conjugate vaccine solution for injection (CAPEXIVE) was related (reported as "got sick with pneumococcal 21-valent conjugate vaccine solution for injection (CAPEXIVE)").